These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 33127889)

  • 1. SARS-CoV-2 spike protein: flexibility as a new target for fighting infection.
    Pierri CL
    Signal Transduct Target Ther; 2020 Oct; 5(1):254. PubMed ID: 33127889
    [No Abstract]   [Full Text] [Related]  

  • 2. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
    Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biophotonics in Health Care and Its Relevance in Fighting the Coronavirus Disease.
    Brugnera Junior A; Zanin F; Nammour S; Groisman S
    Photobiomodul Photomed Laser Surg; 2020 Sep; 38(9):521-523. PubMed ID: 32936069
    [No Abstract]   [Full Text] [Related]  

  • 4. [Not Available].
    Meylan P
    Rev Med Suisse; 2020 Aug; 16(701):1470. PubMed ID: 32833376
    [No Abstract]   [Full Text] [Related]  

  • 5. SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines.
    Salvatori G; Luberto L; Maffei M; Aurisicchio L; Roscilli G; Palombo F; Marra E
    J Transl Med; 2020 Jun; 18(1):222. PubMed ID: 32493510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 spike behavior in situ: a Cryo-EM images for a better understanding of the COVID-19 pandemic.
    Ismail AM; Elfiky AA
    Signal Transduct Target Ther; 2020 Oct; 5(1):252. PubMed ID: 33127886
    [No Abstract]   [Full Text] [Related]  

  • 7. Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications.
    Farsalinos K; Eliopoulos E; Leonidas DD; Papadopoulos GE; Tzartos S; Poulas K
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32823591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus).].
    Lvov DK; Alkhovsky SV
    Vopr Virusol; 2020; 65(2):62-70. PubMed ID: 32515561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mRNA Vaccines: Possible Tools to Combat SARS-CoV-2.
    Yi C; Yi Y; Li J
    Virol Sin; 2020 Jun; 35(3):259-262. PubMed ID: 32524253
    [No Abstract]   [Full Text] [Related]  

  • 10. SARS-CoV-2: Zoonotic origin of pandemic coronavirus.
    Vilcek S
    Acta Virol; 2020; 64(3):281-287. PubMed ID: 32985202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential pathogenesis of severe acute respiratory syndrome coronavirus 2.
    Wu T; Zhang H; Hu E; Ma J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):591-597. PubMed ID: 32879112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2.
    Li X; Zai J; Zhao Q; Nie Q; Li Y; Foley BT; Chaillon A
    J Med Virol; 2020 Jun; 92(6):602-611. PubMed ID: 32104911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26.
    Vankadari N; Wilce JA
    Emerg Microbes Infect; 2020; 9(1):601-604. PubMed ID: 32178593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Light and corona: guided-wave readout for coronavirus spike protein-host-receptor binding.
    Fedotov IV; Yi Z; Voronin AA; Svidzinsky AA; Sower K; Liu X; Vlasova E; Peng T; Liu X; Moiseev SA; Belousov VV; Sokolov AV; Scully MO; Zheltikov AM
    Opt Lett; 2020 Oct; 45(19):5428-5431. PubMed ID: 33001920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interrupted Chain of Transmission in a Pediatric COVID-19 Case.
    Grautoff S
    Klin Padiatr; 2020 Sep; 232(5):272-274. PubMed ID: 32851633
    [No Abstract]   [Full Text] [Related]  

  • 16. The hothouse for protein design.
    Seydel C
    Nat Biotechnol; 2020 Jul; 38(7):779-784. PubMed ID: 32576990
    [No Abstract]   [Full Text] [Related]  

  • 17. Targeting complement activation in COVID-19.
    Kulkarni HS; Atkinson JP
    Blood; 2020 Oct; 136(18):2000-2001. PubMed ID: 33119763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-protease Treatments Targeting Plasmin(ogen) and Neutrophil Elastase May Be Beneficial in Fighting COVID-19.
    Thierry AR
    Physiol Rev; 2020 Oct; 100(4):1597-1598. PubMed ID: 32639219
    [No Abstract]   [Full Text] [Related]  

  • 19. SARS-CoV-2 viral spike G614 mutation exhibits higher case fatality rate.
    Becerra-Flores M; Cardozo T
    Int J Clin Pract; 2020 Aug; 74(8):e13525. PubMed ID: 32374903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bimodular effects of D614G mutation on the spike glycoprotein of SARS-CoV-2 enhance protein processing, membrane fusion, and viral infectivity.
    Jiang X; Zhang Z; Wang C; Ren H; Gao L; Peng H; Niu Z; Ren H; Huang H; Sun Q
    Signal Transduct Target Ther; 2020 Nov; 5(1):268. PubMed ID: 33203835
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.